Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,241,157
+$866,999 QoQ
Shares Held
20,828
+3.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,282
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HBK Sorce Advisory LLC holds $60,692,879 across 13 Drug Manufacturers - General names. ABBV ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,310 | $20,762,135 | |
| 2 | JNJ |
Johnson & Johnson
|
44,818 | $11,382,427 | |
| 3 | MRK |
Merck & Co., Inc.
|
54,037 | $6,943,754 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
20,828 | $5,241,157 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
30,439 | $3,845,663 | |
| 6 | PFE |
Pfizer Inc
|
157,717 | $3,797,825 | |
| 7 | AMGN |
Amgen Inc
|
9,769 | $3,537,550 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
40,142 | $2,312,982 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,241,157 | 20,828 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,374,158 | 20,112 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,672,620 | 20,450 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,916,288 | 21,233 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $3,897,091 | 20,995 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $4,299,769 | 20,522 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,699,003 | 20,816 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,109,756 | 20,811 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,543,774 | 20,661 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,979,249 | 21,852 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,363,158 | 21,702 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $3,319,417 | 22,269 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,910,302 | 21,601 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $3,919,545 | 24,594 | Shares | Sole | 2023-08-15 | |
| 2022-12-31 | $8,468,364 | 52,400 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,440,875 | 25,638 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,263,686 | 21,309 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,533,568 | 27,966 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,532,450 | 26,089 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,758,451 | 25,572 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,683,873 | 23,827 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,471,636 | 22,839 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,401,445 | 22,412 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,865,141 | 21,294 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,136,004 | 21,756 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,532,028 | 20,108 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||